Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report

BACKGROUND: Genetic factors as predictor of the individual outcome of drug therapy is one aim of personalized medicine approaches. CASE PRESENTATION: We report a drug metabolism based analysis of genetic polymorphisms in a Caucasian patient receiving fluvastatin and telmisartan experiencing myotoxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer zu Schwabedissen, Henriette E, Siegmund, Werner, Kroemer, Heyo K, Rollnik, Jens D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192324/
https://www.ncbi.nlm.nih.gov/pubmed/25280537
http://dx.doi.org/10.1186/1756-0500-7-688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192324/
https://www.ncbi.nlm.nih.gov/pubmed/25280537
http://dx.doi.org/10.1186/1756-0500-7-688

Ejemplares similares